Pew and the Stewart Trust launch scholars program targeting cancer

June 24, 2014

Philadelphia--The Pew Charitable Trusts and the Alexander and Margaret Stewart Trust announced the inaugural class of Pew-Stewart Scholars for Cancer Research. Five promising early-career scientists will receive funding for research aimed at finding cures for cancer using approaches that include genetics, pharmacology, and structural biology.

"Cancer continues to take a terrible toll on human health worldwide, and creative approaches are vital for the development of novel therapies," said Rebecca W. Rimel, Pew's president and CEO. "We are delighted to partner with the Stewart Trust to expand our commitment to science and eagerly anticipate the discoveries these talented researchers will make to address these challenges."

Pew has supported innovative research by young scientists through its biomedical scholars program since 1985 and through the Pew Latin American fellows program launched in 1991.

"Some of the most important health advances have stemmed from curiosity-driven investigations, and young researchers seem particularly primed to seed innovation in the field of cancer," said William Bierbower, executive trustee for the Stewart Trust, which for over 15 years has backed researchers probing the mechanisms of cancer.

"By combining forces with Pew, whose biomedical programs set the standard for selecting outstanding researchers, we believe we can leverage the most talented scientific minds to discover novel means of preventing, treating, and eventually curing cancer."

The Pew-Stewart scholars are assistant professor-level cancer researchers. They receive funding over four years and will have the opportunity to collaborate with Pew biomedical scholars and Latin American fellows at Pew's annual biomedical meeting.

Also announced today were the newest members of Pew's biomedical scholars and Latin American fellows programs, which support groundbreaking research by promising early-career biomedical researchers in the United States and Latin America.

The 2014 Pew-Stewart Scholars for Cancer Research are:

Arvin Dar, Ph.D.
Icahn School of Medicine at Mount Sinai
Oncology and chemical biology

Andrew Holland, Ph.D.
Johns Hopkins University School of Medicine
Cell biology and oncology

Shawn Douglas, Ph.D.
University of California, San Francisco
Pharmacology and nanotechnology

Agnel Sfeir, Ph.D.
New York University School of Medicine
Chromosome biology

Roberto Zoncu, Ph.D.
University of California, Berkeley
Cell biology and cancer metabolism

For the scholars' full abstracts and for more information about the program, please visit http://www.pewtrusts.org/projects/Pew-Stewart-Scholars-for-Cancer-Research/.
-end-
The Pew Charitable Trusts is driven by the power of knowledge to solve today's most challenging problems. Learn more at http://www.pewtrusts.org.

Established in 1947, the Alexander and Margaret Stewart Trust is a charitable foundation supporting nonprofit organizations that research, treat, and prevent cancer and pediatric illnesses. The Stewart Trust distributed over $4 million in grants in calendar year 2009. For 50 years, the Trust awarded grants largely for cancer treatment--principally for indigent care and for hospice services. Learn more at http://www.stewart-trust.org.

Pew Charitable Trusts

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.